- ►annals.org P Schuman, L Capps, G Peng, J Vazquez, W … - Annals of internal medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Candidiasis is a frequent complication of infection with the ... Cited by 99 - Related articles - BL Direct - All 5 versions
DV Havlir, MP Dubé, JA McCutchan, DN … - Clinical Infectious Diseases, 1998 - UChicago Press Page 1. 1369 Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections
in Patients with AIDS Diane V. Havlir, Michael P. Dubé, J. Allen McCutchan, ... Cited by 55 - Related articles - BL Direct - All 3 versions
DA Stevens, SI Greene, OS Lang - Archives of Internal Medicine, 1991 - archinte.highwire.org Recurrent oropharyngeal candidiasis is common in pa- tients with acquired
immunodeficiency syndrome and the acquired immunodeficiency syndrome\p=m-\
relatedcomplex. It causes local pain and discomfort, loss of taste, and ... Cited by 48 - Related articles - All 4 versions
WG Powderly, DM Finkelstein, J Feinberg, P … - New England Journal of Medicine, 1995 - content.nejm.org Results After a median follow-up of 35 months, invasive fungal infections had
developed in 4.1 percent of the patients in the fluconazole group (9 of 217) and
in 10.9 percent of those in the clotrimazole group (23 of 211; relative ... Cited by 230 - Related articles - BL Direct - All 5 versions
JR Maenza, JC Keruly, RD Moore, RE … - The Journal of infectious diseases, 1996 - jstor.org Page 1. 219 Risk Factors for Fluconazole-Resistant Candidiasis in Human
Immunodeficiency Virus-Infected Patients Janine R. Maenza ... Cited by 130 - Related articles - BL Direct - All 4 versions
DJ Marriott, PD Jones, JF Hoy, BR Speed, JL … - The Medical journal of Australia, 1993 - ncbi.nlm.nih.gov OBJECTIVE: To assess the efficacy and tolerance of fluconazole (150 mg oral
dose, once a week) in the prevention of recurrent oropharyngeal candidiasis in
patients with moderate to severe human immunodeficiency virus (HIV) ... Cited by 28 - Related articles - BL Direct - All 2 versions
P Phillips, J Zemcov, W Mahmood, JSG … - Aids, 1996 - journals.lww.com 1370 AIDS 1996, Vol 10 No 12 Introduction Azole resistance among Candida
albicans isolates was first reported with miconazole in 1978 [1]. Reports of
resis- tance to ketoconazole began to appear a few years later in a few ... Cited by 76 - Related articles - BL Direct - All 4 versions
CL Leen, EM Dunbar, ME Ellis, BK Mandal - The Journal of infection, 1990 - ncbi.nlm.nih.gov Fluconazole 50 mg daily for 14-28 days was effective in the treatment of
patients with AIDS and AIDS-related complex with severe oropharyngeal and
oesophageal candidiasis. Of 24 patients entered, 17 (81%), including seven ... Cited by 51 - Related articles - All 2 versions
V Pons, D Greenspan, F Lozada-Nur, L … - Clinical Infectious Diseases, 1997 - UChicago Press Page 1. 1204 Oropharyngeal Candidiasis in Patients with AIDS: Randomized
Comparison of Fluconazole Versus Nystatin Oral Suspensions ... Cited by 60 - Related articles - BL Direct - All 4 versions
LA MacPhail, JF Hilton, CL Dodd, D … - JAIDS Journal of Acquired Immune Deficiency …, 1996 - journals.lww.com Summary: To determine whether daily use of nystatin pastilles can prevent
initial outbreak or recurrence of oral candidiasis in HIV-infected patients and
to identify factors associated with outbreaks during 20-week follow-up, a ... Cited by 24 - Related articles - BL Direct - All 4 versions
